As ERβ over-expression increases PTEN levels in a ligand-independent manner [34], it could be speculated that upregulation of PTEN protein expression is a common anti-tumor mechanism of ERβ; however, this experiment was performed using 293T cells rather than glioma cells. The gene discussed is PTEN; the disease is central nervous system cancer.